Lung cancer pathogenesis and poor response to therapy were dependent on driver oncogenic mutations.

doi:10.1016/j.lfs.2020.118797

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Lung cancer pathogenesis and poor response to therapy were dependent on driver oncogenic mutations.

Life sciences - 15 Jan 2021

Sun Xin, Li Kai, Zhao Rui, Sun Ye, Xu Jie, Peng Zi-Yang, Song Run-Dong, Ren Hong, Tang Shou-Ching

Abstract excerpt

AIMS: Lung cancer was the most fatal malignancy, dominated the cancer related mortality list for years, and we tried to distinguish the lung adenocarcinoma patients at higher risk from those bearing lower therapy resistance and recurrence risk. MATERIALS: Patients information from clinical Sequencing Cohorts and from the Regional Medical Center of the Middle-West China were included. The whole-exome sequencing...

Topics

Adenocarcinoma of Lung
Aged
Biomarkers, Tumor
Carcinogenesis
Female
Humans
Lung Neoplasms
Male
Middle Aged
Mutation
Oncogenes
Smoking
Survival Rate
Treatment Outcome

Source

Open in PubMed

Identifiers

PMID: 33285162
DOI: 10.1016/j.lfs.2020.118797

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics